Zydus appoints Punit Patel as President and CEO, Americas
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
The new gummy capabilities include a dedicated R&D lab, an automated production line, and bottle packaging solutions
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Advances Amgen's mission to serve patients with rare disease medicines
The Main campaign started from October 2
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
Subscribe To Our Newsletter & Stay Updated